Skip to main content
NIH funding notice RFA-DA-25-047

Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)

Closed on November 17, 2025.

Posted
September 28, 2023
Close date
November 17, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $306,678 in first-year total cost, median $306,678.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 SKM-S (O1)]1

Most frequent institutions

  1. HART3S - A SOCIAL PURPOSE CORPORATION1
Competing awards under RFA-DA-25-047 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder1R41DA062292-01COLLINS, SUSAN ELIZABETHHART3S - A SOCIAL PURPOSE CORPORATION, WA$306,678ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DA-25-047: Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) | ScienceDex | ConductScience